Prognosis and complete remission rate of diffuse large B‐cell lymphoma patients in standard R‐CHOP with reduction of vincristine: A retrospective study

BACKGROUND AND AIMS: The effect of stopping or reducing the dose of vincristine in diffuse large B‐cell lymphoma (DLBCL) on the outcome and prognosis of the disease is still in doubt. The present study aimed to investigate and compare the prognosis and complete remission of two R‐CHOP treatment regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Riasi, Fatemeh, Ataei Azimi, Sajjad, Allahyari, Abolghasem, Moeini Nodeh, Mohammad, Shakeri, Mohammad T., Kamandi, Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684988/
https://www.ncbi.nlm.nih.gov/pubmed/38033714
http://dx.doi.org/10.1002/hsr2.1716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684988/
https://www.ncbi.nlm.nih.gov/pubmed/38033714
http://dx.doi.org/10.1002/hsr2.1716

Ejemplares similares